NASDAQ · LZOEX · USD
Stock price, dividends
Quote as of Oct 30, 2026, 12:10 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Lazard Emerging Markets Equity Portfolio’s quoted price sits in the upper half of its reported 52-week range, 6.48% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Lazard Emerging Markets Equity Portfolio’s forward annual dividend is $0.45 per share, paid annual. The forward yield is 1.4% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The Lazard Emerging Markets Equity Portfolio primarily allocates its capital to equity holdings, specifically common shares, of businesses operating predominantly in developing economies outside the U.S. The Investment Manager targets companies believed to be trading below their intrinsic worth, a determination made through analysis of their profitability, cash generation, or underlying asset values. Typically, at least 80% of the fund's assets are dedicated to equity securities of companies with substantial operations in emerging market countries during normal market conditions.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:23 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
THE ANALYST VIEW
1 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$30.74-$0.12 (-0.39%)
Lazard Emerging Markets Equity Portfolio R6 Shares’s quoted price sits in the upper half of its reported 52-week range, 6.42% below the high.
$43.87+$0.65 (+1.5%)
DFA U.S. Targeted Value Portfolio’s quoted price sits in the upper half of its reported 52-week range, 3.18% below the high.
$27.43-$0.01 (-0.04%)
DFA International Small Company Portfolio’s quoted price sits in the upper half of its reported 52-week range, 5.18% below the high.
$34.15$0.00 (0.0%)
DFA International Small Cap Value Portfolio’s quoted price sits in the upper half of its reported 52-week range, 6.41% below the high.
$29.00-$0.02 (-0.07%)
Templeton Growth Fd, Inc. Class A’s quoted price sits in the lower half of its reported 52-week range, 10.16% below the high.
$59.70-$0.88 (-1.45%)
American Century Growth Investor Class’s quoted price sits in the upper half of its reported 52-week range, 13.4% below the high.
$51.26-$0.15 (-0.29%)
DFA US Large Company Portfolio’s quoted price sits in the upper half of its reported 52-week range, 1.21% below the high.
$28.31+$0.18 (+0.64%)
MFS Mid Cap Growth I’s quoted price sits in the lower half of its reported 52-week range, 14.68% below the high.
